BRKR Stock: Price, Earnings History and SEC Filings
Bruker Corporation (BRKR) last traded at $57.07, down 7.95% on the latest session and down 11.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.49 against an analyst estimate of $0.38, a beat of 28.9%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BRKR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $0.49 | $0.38 | +28.95% |
| Mar 2026 | May 6, 2026 | $0.31 | $0.23 | +34.78% |
| Dec 2025 | Feb 12, 2026 | $0.59 | $0.65 | -9.23% |
| Sep 2025 | Nov 3, 2025 | $0.45 | $0.33 | +36.36% |
BRKR beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How BRKR reacts to earnings
Across its last 8 earnings releases, BRKR moved 8.9% on average the next session, in either direction. It rose after 2 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-04 | Before open | -21.79% |
| 2026-05-06 | Before open | +11.29% |
| 2026-02-12 | Before open | -11.60% |
| 2026-01-12 | Before open | -1.93% |
| 2025-11-03 | Before open | -0.59% |
| 2025-08-04 | Before open | -8.61% |
| 2025-07-21 | Before open | -12.11% |
| 2025-05-07 | Before open | +3.32% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
BRKR financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $3.4B | -$9M | $43M | -0.3% | $-0.15 |
| 2024 | $3.4B | $113M | $136M | 3.4% | $0.76 |
| 2023 | $3.0B | $427M | $243M | 14.4% | $2.90 |
| 2022 | $2.5B | $297M | $145M | 11.7% | $1.99 |
| 2021 | $2.4B | $277M | $190M | 11.5% | $1.81 |
| 2020 | $2.0B | $158M | $235M | 7.9% | $1.02 |
| 2019 | $2.1B | $197M | $140M | 9.5% | $1.26 |
| 2018 | $1.9B | $180M | $191M | 9.5% | $1.14 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for BRKR
- 8-K · Oct 29, 2026Other events
- 8-K · Aug 14, 2026Other events
- 10-Q · Aug 5, 2026
- 8-K · Aug 4, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 30, 2026Other events
- 8-K · May 21, 2026Shareholder vote
- 8-K · May 15, 2026Other events
- 10-Q · May 7, 2026
- 8-K · May 6, 2026Results of operations, Financial statements and exhibits
- 8-K · Apr 28, 2026Other events
Insider filing activity
BRKR insiders filed 14 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
BRKR news
- 3 small-cap stocks we find riskyOct 29, 2026 · finance.yahoo.com
- 1 healthcare stock for long-term investors and 2 we ignoreOct 26, 2026 · finance.yahoo.com
- Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and WebcastOct 20, 2026 · finance.yahoo.com
About Bruker Corporation
Bruker Corporation (BRKR) is a US-listed public company on Nasdaq. The SEC classifies its business as Laboratory Analytical Instruments. It is incorporated in DE. Its fiscal year ends in December.